A detailed history of Luts & Greenleigh Group, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Luts & Greenleigh Group, Inc holds 4,443 shares of MRK stock, worth $435,636. This represents 0.48% of its overall portfolio holdings.

Number of Shares
4,443
Previous 4,484 0.91%
Holding current value
$435,636
Previous $555 Million 9.12%
% of portfolio
0.48%
Previous 0.58%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$111.15 - $128.97 $4,557 - $5,287
-41 Reduced 0.91%
4,443 $504 Million
Q2 2024

Aug 09, 2024

SELL
$123.8 - $132.96 $122,314 - $131,364
-988 Reduced 18.06%
4,484 $555 Million
Q4 2023

Jan 29, 2024

BUY
$100.18 - $109.02 $4,007 - $4,360
40 Added 0.74%
5,472 $597 Million
Q3 2023

Nov 01, 2023

SELL
$102.95 - $114.33 $19,972 - $22,180
-194 Reduced 3.45%
5,432 $559 Million
Q2 2023

Jul 17, 2023

BUY
$108.61 - $118.38 $16,508 - $17,993
152 Added 2.78%
5,626 $649 Million
Q1 2023

Apr 13, 2023

BUY
$102.94 - $114.86 $4,838 - $5,398
47 Added 0.87%
5,474 $582 Million
Q4 2022

Mar 30, 2023

BUY
$87.44 - $112.11 $474,536 - $608,420
5,427 New
5,427 $602 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Luts & Greenleigh Group, Inc Portfolio

Follow Luts & Greenleigh Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Luts & Greenleigh Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Luts & Greenleigh Group, Inc with notifications on news.